Conceptual framework for the medical management of heart failure (HF) with reduced or preserved ejection fraction (HFrEF or HFpEF) and chronic kidney disease (CKD) ca. 2026 from @kdigo.org @kidneyint.bsky.social
#Nephpearls #Cardiorenal #NephSky
👉 pubmed.ncbi.nlm.nih.gov/41793402/
GDMT for HFpEF and HFrEF
#Nephpearls #Cardiorenal #NephSky
👉🏼 www.acc.org/Education-an...
Check out our review "IgA Nephropathy #IgAN: An Overview of the Clinical Trials" #Nephmadness write up
#Nephpearls #NephSky
👉 pubmed.ncbi.nlm.nih.gov/41050133/
👉 NephMadness ajkdblog.org/2026/03/01/n...
C3 Glomerulopathy Diagnosis, Current Treatments, and Emerging Therapies ca. 2026 from @kidneymed.bsky.social @saynanorouzi.bsky.social
📢 This paper is a very timely read for #NephMadness
#Nephpearls #NephSky
👉🆓 www.sciencedirect.com/science/arti...
👉 ajkdblog.org/2026/03/01/n...
It’s March once again … #Nephmadness has begun #Nephpearls #NephSky
👉🏼 ajkdblog.org
👉🏼 If you don’t know what it’s about, then it’s time to checkout this 📺 m.youtube.com/watch?v=tZUR...
C3 Glomerulopathy Diagnosis, Current Treatments, and Emerging Therapies ca. 2026 from @kidneymed.bsky.social @jzrenalpath.bsky.social @drraymondhsu.bsky.social @saynanorouzi.bsky.social
#Nephpearls
👉 www.sciencedirect.com/science/arti...
Which patients with CKD should be on SGLT2 inhibitors (SGLT2i) ⁉️
#Nephpearls #NephSky
✅ Check out our Cold 🥶 map from @theisn.org @isnkidneycare.bsky.social
👉 www.theisn.org/initiatives/...
Dialysis Dysequilibrium Syndrome
#Nephpearls #AKIinICU #NephSky
📌 Reverse Urea Hypothesis
📌 Idiogenic Osmole Hypothesis
📌 High Dialysate Bicarbonate
👉 shop.lww.com/Handbook-of-...
Real-World Hospitalization Outcomes with On-Line Hemodiafiltration Versus High-Flux Hemodialysis ca. 2025 from @asnpublications.bsky.social
#Nephpearls #NephSky
#VisualAbstract by @husamjz.bsky.social
👉 pubmed.ncbi.nlm.nih.gov/41433104/
Flowsheet for the potential escalation of diuretics in patients with refractory hypervolemia
#Nephpearls #Cardiorenal #NephSky
👉 www.wolterskluwer.com/en/solutions...
Capillary refill time (CRT) measured in digital nail bed blood return is quick, easily performed, and a long-standing component of the physical exam in the ICU
#Nephpearls #AKIinICU #NephSky
👉 www.wolterskluwer.com/en/solutions...
👉 pubmed.ncbi.nlm.nih.gov/30772908/
Simultaneous initiation of finerenone and empagliflozin was effective and well tolerated among CONFIDENCE study participants from Asia, consistent with the overall population ca. 2026 from @asnpublications.bsky.social
#Nephpearls #NephSky
👉 pubmed.ncbi.nlm.nih.gov/40965042/
New terminology for iron deficiency in CKD ca. 2026 from @kdigo.org
#Nephpearls #NephSky
Systemic iron deficiency
(previously Absolute iron deficiency)
⬇️ Ferritin ⬇️TSAT
Iron-restricted erythropoiesis
(previously Functional iron deficiency)
⬆️ Ferritin ⬇️ TSAT
👉 kdigo.org/guidelines/a...
Super Bowl 🏈 LX commercial highlighting UACR
#Nephpearls #NephSky #SuperBowlLX
youtu.be/GO6Lq8lLlVU?...
Iron treatment may be considered in people with CKD and profound iron deficiency (ferritin <30 ng/ml [<30 mg/l] and TSAT <20%) in the absence of anemia, especially in the presence of symptoms ca. 2026 from @kdigo.org
#Nephpearls #NephSky
👉 kdigo.org/guidelines/a...
Low-grade proteinuria, whether assessed at baseline or over time, is an important predictor of kidney disease progression in patients with IgA nephropathy #IgAN ca. 2026 from @asnpublications.bsky.social
#Nephpearls #NephSky
👉🏼 pubmed.ncbi.nlm.nih.gov/41385286/
Editors’ Choice 2025: Efficacy and Safety of Ravulizumab in IgA Nephropathy: A Phase 2 Randomized Double-Blind Placebo-Controlled Trial
This phase 2 trial tested ravulizumab, a complement C5 inhibitor, in adults with IgA nephropathy.
Check out the paper here: kidney.pub/JASN0534
Although often used interchangeably, dehydration & volume depletion are not the same
#Nephpearls #NephSky
📌 Dehydration refers to “loss of total body water” (leads to hypertonicity)
📌 Volume depletion refers to an ECFV deficit
👉🏼 pubmed.ncbi.nlm.nih.gov/21705120/
CKD for the Primary Care Provider ca. 2026
#Nephpearls #NephSky
👉 pubmed.ncbi.nlm.nih.gov/41152063/
Check out 👉🏼 From Variant to Bedside, Making Genetics 🧬 Routine in #Nephrology
#Nephpearls #NephSky
@saynanorouzi.bsky.social
This is our choice for ⚡️Kidney Watch⚡️ 2026 published in the January 2026 issue of @asnpublications.bsky.social
👉 www.kidneynews.org/view/journal...
Nephrology #Survey on #Reproductive #Health and Kidney Disease
#VisualAbstract by Edgar V. Lerma 🇵🇭
https://www.kireports.org/article/S2468-0249(25)00748-X/fulltext
Spectrum of glomerulonephritis from @neilturn.bsky.social
#Nephpearls #NephSky
👉 shop.lww.com/Handbook-of-...
Kidney Biopsy 🔬 101 from @changucanspare.bsky.social
#Nephpearls #NephSky
👉 shop.lww.com/Handbook-of-...
Management of anemia in CKD ca. 2026 from @kdigo.org
#Nephpearls #NephSky
👉 kdigo.org/guidelines/a...
Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease (CKD) ca. 2026 from @kdigo.org
#Nephpearls #NephSky
👉 kdigo.org/guidelines/a...
Classification of glomerular diseases based on main pathogenic 🔬 mechanisms
#Nephpearls #NephSky
👉 shop.lww.com/Handbook-of-...
Obesity‑related glomerulopathy, A growing kidney burden in the obesity pandemic ca. 2025 from @jzrenalpath.bsky.social @saynanorouzi.bsky.social
#Nephpearls #NephSky
👉 pubmed.ncbi.nlm.nih.gov/41410808/
CHAPERONE: Cardiovascular Kidney & Metabolic (CKM) Health Assessment & Patient Empowerment in chROnic Disease using a Health Coach iNtervention ModEl: A Randomized Clinical Trial Design ca. 2025
#AHA25 🇺🇸 #AHA2025 🇺🇸 #Nephpearls #Cardiorenal #NephSky
www.ahajournals.org/doi/abs/10.1...
Integrating Oral Health Into #Kidney Care: A Policy Imperative for Chronic Kidney Disease (CKD), the US Experience ca. 2026 from #InternationalDentalJournal
#NephSky
👉🏼 www.sciencedirect.com/science/arti...
Hypocomplementemia in glomerulonephritis: Testing for "complement activation" is an essential early step in the evaluation of glomerular disease
#Nephpearls #NephSky
👉🏼 shop.lww.com/Handbook-of-...
